Immunesensor Therapeutics
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2110 Research Row Ste 610, Dallas, Texas...Phone Number
(469) 570-5330Website
www.immunesensor.comRevenue
<$5 MillionIndustry
About Immunesensor Therapeutics
ImmuneSensor Therapeutics is a clinical-stage biotechnology company specializing in the development of innovative medicines that target the cGAS-STING pathway to modulate the innate immune system. The company aims to create best-in-class cGAS inhibitors to address inflammatory and autoimmune diseases, leveraging groundbreaking research from Dr. Zhijian James Chen. Their approach is based on the recognition of the cGAS-STING pathway's critical role in innate immunity and its potential in various therapeutic applications. ImmuneSensor Therapeutics is committed to advancing drug development efforts to improve patient outcomes in these challenging health areas.Explore more
Immunesensor Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Immunesensor Therapeutics
Compare insights from companies similar to Immunesensor Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immunesensor Therapeutics
<$5M
1-10
Private
<$5M
2014
BL
Betty LawrenceVice President, Toxicology & Regulatory
Immunesensor Therapeutics Tech Stack
A closer look at the technologies used by Immunesensor Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunesensor Therapeutics
Sign Up For FreeTo access detailed company insights
ImmuneSensor Therapeutics is a clinical-stage biotechnology company specializing in the development of innovative medicines that target the cGAS-STING pathway to modulate the innate immune system. The company aims to create best-in-class cGAS inhibitors to address inflammatory and autoimmune diseases, leveraging groundbreaking research from Dr. Zhi... Read More
